John J. Alam, EVP, Med. Development Group & CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 802 shares at $27.47 ($22K) on 2008-05-20, disclosed to the SEC on 2008-05-22.
Scheduled sale ($22k) by EVP, Med. Development Group & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.47 | 161 | $4K | 20.0% |
| 2 | $27.54 | 80 | $2K | 9.9% |
| 3 | $27.59 | 80 | $2K | 10.0% |
| 4 | $27.61 | 160 | $4K | 19.9% |
| 5 | $27.64 | 81 | $2K | 10.1% |
| 6 | $27.65 | 80 |
| $2K |
| 10.0% |
| 7 | $27.71 | 80 | $2K | 10.0% |
| 8 | $27.89 | 80 | $2K | 10.1% |
| Total | $27.62 avg | 802 | $22K | 100% |
| Filing → |
| CRVO | BUY | 2025-11-13 | $41K | — | Filing → |
| VRTX | SELL | 2008-10-02 | $139K | — | Filing → |
| VRTX | SELL | 2008-09-11 | $173K | — | Filing → |